atrial fibrillation
Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
February 12, 2026Research and Development Cardiology, Rhythm AI, atrial fibrillation
Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
Acesion Pharma raises €45m series B funding
September 26, 2023Business Services Acesion Pharma, Cardiology, atrial fibrillation, series B financing
Acesion Pharma has announced that it has closed an oversubscribed €45m series B financing round. This financing was co-led by …
Correvio’s atrial fibrillation drug voted down by FDA committee over safety concerns
December 11, 2019Research and Development, Sales and Marketing Correvio Pharma, FDA, atrial fibrillation, pharma
It has emerged that Correvio Pharma’s anti-arrhythmic therapy Brinavess was shot down by the FDA’s Cardiovascular and Renal Drugs Advisory …
AI accurately detects subtle signs of atrial fibrillation even in normal tests
August 2, 2019Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma
A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …
Two biomarkers can aid in atrial fibrillation screening, researchers find
January 8, 2019Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma
A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …
Living with atrial fibrillation
April 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KardiaMobile, Tony Green, atrial fibrillation, patient experience
Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …
The April 2018 issue of Pharmafocus is now live!
March 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma
As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …
Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation
February 14, 2018Research and Development KardiaMobile, NHS, atrial fibrillation, pharma
AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic …
1 in 6 US patients are given wrong dose of blood-thinners, study suggests
June 7, 2017Research and Development Mayo Clinic, atrial fibrillation, blood thinner, blood-thinner
New research data from the Mayo Clinic has suggested that as much as one in six patients suffering from atrial …
Bayer backs safety of Xarelto after real-world data study
September 2, 2015Research and Development Bayer, ESC, European Society of Cardiology, Xarelto, anticoagulants, atrial fibrillation, real-word evidence, rivaroxaban
Around 96 in every 100 people treated with Bayer’s anticoagulant Xarelto do not experience any major bleeding, related side effects …
Daiichi scores another NICE nod for Lixiana
August 12, 2015Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban
NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …
Daiichi Sankyo launches clotting drug Lixiana in UK
July 10, 2015Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin
Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …
Daiichi-Sankyo blood drug gets FDA nod
January 12, 2015Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa
The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …
Merck ends development on atrial fibrillation pill
March 20, 2012Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation
Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
NICE recommends Pradaxa for stroke prevention
March 15, 2012Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation
NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …
